Davis to leave Takeda UK

pharmafile | September 30, 2005 | News story | Sales and Marketing |   

Andy Davis, the high-profile managing director of Takeda UK is to leave the company.

Davis is best known for overseeing a radical restructure of the medium-sized company, making redundant the company's entire salesforce and rebuilding the firm around a new regional account manager system.

Davis has headed up the UK division of the Japanese pharmaceutical company for around five years and is understood to be leaving the industry for a position with Virgin – just the kind of consumer company Davis had sought to emulate at Takeda in its focus on meeting customer needs in innovative ways.

Advertisement

Davis was not available for comment, but a source at Takeda said his departure was completely amicable and confirmed Davis was looking for a "new challenge".

Takeda launched its network of regional account directors (RADs) in early 2005, after dismissing its entire salesforce of 168 a year earlier.

The company found sales of its lead products – diabetes treatment Actos and hypertension drug Amias – continued to rise despite no salesforce promoting them during the period.

Davis argued that large salesforces were unsustainable for medium-sized pharma companies, and said the aims of the restructure was to improve return on investment, respond more effectively to NHS needs, and to attract the best talent.

Related articles:

NHS is behind us, says rep-free Takeda

Tuesday , March 01, 2005

 

 

Related Content

No items found
The Gateway to Local Adoption Series

Latest content